FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280530665> ?p ?o ?g. }

• W4280530665 endingPage "e1333" @default.
• W4280530665 startingPage "e1320" @default.
• W4280530665 abstract "PURPOSE: Patients' concerns regarding clinical trial (CT) participation include apprehension about side effects, quality of life (QoL), financial burden, and quality of care. METHODS: We prospectively evaluated the experience of patients with multiple myeloma or lymphoma who were treated on CTs (CT group, n = 35) versus patients treated with standard approaches (non-CT group, n = 88) focusing on QoL, financial burden of care, and patients' perception of quality of care over a 1-year period. RESULTS: There were no significant differences in any of the patient-reported outcomes in CT versus non-CT groups. We observed an initial decline in overall QoL in the first 3 months across both groups, driven primarily by physical and functional well-being. QoL gradually improved and was above baseline by month 12. Patients reported highest improvement in the functional well-being subdomain. Patients in both groups reported high satisfaction with the quality of care received, and there were no differences in overall satisfaction, communication with team, or access to care. At baseline, 16%-19% of patients reported financial burden, which increased to a peak of 33% in the CT group and to 49% in the non-CT group over the course of 1 year. There was no significant difference in financial burden in the two groups overall. Most of the patients reported getting all the care that was deemed medically necessary in both groups. However, a significant proportion of patients reported having to make other kinds of financial sacrifices because of their cancer (CT group: 33% of patients at baseline and 21%-40% over 1 year; non-CT group: 19% at baseline and 25%-36% over 1 year). CONCLUSION: Patients treated on CTs reported comparable QoL and quality of care with the non-CT group. A high proportion of patients reported financial burden over time in both groups. Our findings can serve as a guide to educate patients regarding CT participation and highlight the need to address the significant financial burden experienced by patients with cancer." @default.
• W4280530665 created "2022-05-22" @default.
• W4280530665 creator A5000308170 @default.
• W4280530665 creator A5002248011 @default.
• W4280530665 creator A5004152557 @default.
• W4280530665 creator A5008583422 @default.
• W4280530665 creator A5011479243 @default.
• W4280530665 creator A5017390274 @default.
• W4280530665 creator A5024819739 @default.
• W4280530665 creator A5025688165 @default.
• W4280530665 creator A5026574827 @default.
• W4280530665 creator A5035289098 @default.
• W4280530665 creator A5041306590 @default.
• W4280530665 creator A5056260546 @default.
• W4280530665 creator A5059729547 @default.
• W4280530665 creator A5061713890 @default.
• W4280530665 creator A5068637846 @default.
• W4280530665 creator A5076621021 @default.
• W4280530665 creator A5077867282 @default.
• W4280530665 creator A5080184636 @default.
• W4280530665 creator A5090009905 @default.
• W4280530665 creator A5090694142 @default.
• W4280530665 date "2022-08-01" @default.
• W4280530665 modified "2023-09-25" @default.
• W4280530665 title "Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care" @default.
• W4280530665 cites W1570643662 @default.
• W4280530665 cites W1980935016 @default.
• W4280530665 cites W1989078718 @default.
• W4280530665 cites W1989136584 @default.
• W4280530665 cites W2064370814 @default.
• W4280530665 cites W2076668534 @default.
• W4280530665 cites W2096954217 @default.
• W4280530665 cites W2099354636 @default.
• W4280530665 cites W2101383708 @default.
• W4280530665 cites W2105258029 @default.
• W4280530665 cites W2200220500 @default.
• W4280530665 cites W2218372478 @default.
• W4280530665 cites W2298846890 @default.
• W4280530665 cites W2303577864 @default.
• W4280530665 cites W2407107555 @default.
• W4280530665 cites W2915663023 @default.
• W4280530665 cites W2937533880 @default.
• W4280530665 cites W2946271860 @default.
• W4280530665 cites W2989004662 @default.
• W4280530665 cites W3003309896 @default.
• W4280530665 cites W3016804399 @default.
• W4280530665 cites W3091769743 @default.
• W4280530665 cites W3145596383 @default.
• W4280530665 cites W3150403772 @default.
• W4280530665 cites W3165696219 @default.
• W4280530665 cites W4225556471 @default.
• W4280530665 cites W4240338964 @default.
• W4280530665 doi "https://doi.org/10.1200/op.21.00789" @default.
• W4280530665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35580285" @default.
• W4280530665 hasPublicationYear "2022" @default.
• W4280530665 type Work @default.
• W4280530665 citedByCount "1" @default.
• W4280530665 countsByYear W42805306652023 @default.
• W4280530665 crossrefType "journal-article" @default.
• W4280530665 hasAuthorship W4280530665A5000308170 @default.
• W4280530665 hasAuthorship W4280530665A5002248011 @default.
• W4280530665 hasAuthorship W4280530665A5004152557 @default.
• W4280530665 hasAuthorship W4280530665A5008583422 @default.
• W4280530665 hasAuthorship W4280530665A5011479243 @default.
• W4280530665 hasAuthorship W4280530665A5017390274 @default.
• W4280530665 hasAuthorship W4280530665A5024819739 @default.
• W4280530665 hasAuthorship W4280530665A5025688165 @default.
• W4280530665 hasAuthorship W4280530665A5026574827 @default.
• W4280530665 hasAuthorship W4280530665A5035289098 @default.
• W4280530665 hasAuthorship W4280530665A5041306590 @default.
• W4280530665 hasAuthorship W4280530665A5056260546 @default.
• W4280530665 hasAuthorship W4280530665A5059729547 @default.
• W4280530665 hasAuthorship W4280530665A5061713890 @default.
• W4280530665 hasAuthorship W4280530665A5068637846 @default.
• W4280530665 hasAuthorship W4280530665A5076621021 @default.
• W4280530665 hasAuthorship W4280530665A5077867282 @default.
• W4280530665 hasAuthorship W4280530665A5080184636 @default.
• W4280530665 hasAuthorship W4280530665A5090009905 @default.
• W4280530665 hasAuthorship W4280530665A5090694142 @default.
• W4280530665 hasConcept C126322002 @default.
• W4280530665 hasConcept C159110408 @default.
• W4280530665 hasConcept C1862650 @default.
• W4280530665 hasConcept C2779951463 @default.
• W4280530665 hasConcept C535046627 @default.
• W4280530665 hasConcept C71924100 @default.
• W4280530665 hasConceptScore W4280530665C126322002 @default.
• W4280530665 hasConceptScore W4280530665C159110408 @default.
• W4280530665 hasConceptScore W4280530665C1862650 @default.
• W4280530665 hasConceptScore W4280530665C2779951463 @default.
• W4280530665 hasConceptScore W4280530665C535046627 @default.
• W4280530665 hasConceptScore W4280530665C71924100 @default.
• W4280530665 hasIssue "8" @default.
• W4280530665 hasLocation W42805306651 @default.
• W4280530665 hasLocation W42805306652 @default.
• W4280530665 hasOpenAccess W4280530665 @default.
• W4280530665 hasPrimaryLocation W42805306651 @default.
• W4280530665 hasRelatedWork W2027392011 @default.
• W4280530665 hasRelatedWork W2042534033 @default.

• next